Agora Nova
Chartboost · case study
Jul 7, 2023 · App & gaming

“LoopMe’s bespoke audience was reported result more likely to reach new patients for major pharmaceutical brand , validated by Crossix”

Title as published by Chartboost. Numbers in the title are withheld until Agora Nova verifies them against the original page.

Reported results are the publisher’s claims. Agora Nova has not verified them.View original case study

Who was involved

Brand
LSLoopMe’s bespoke audienceDetected automatically
Agency
None named
Technology
None named
Measurement
None named
Platform
Source
loopme.ai · Partner Programs: Measurement, CTV, App & Gaming, last checked Oct 20, 2026